Transcendental Meditation Intervention to Reduce Burnout and Enhance Resilience Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents
A Pilot Intervention to Reduce Burnout and Enhance Resilience Through Transcendental Meditation Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents
1 other identifier
interventional
15
1 country
1
Brief Summary
The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medicine to help reduce employees' levels of burnout, anxiety, insomnia, and depression as well as to determine the feasibility and acceptability of the meditation practice by Weill Cornell employees. The main question the study aims to answer is whether: • Levels of burnout, anxiety, insomnia, and depression will be decreased, and overall mental well-being will improve over a 3.5-month period before and after TM intervention. Participants will attend 9 sessions total (8 group sessions and 1 individual session) with a certified TM instructor from The David Lynch Foundation Institute for Mental Health and Resilience where they will gain experience in proper TM techniques. Also, participants will conduct 2 of their own TM sessions at home daily during the course of this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable anxiety
Started Nov 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedStudy Start
First participant enrolled
November 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2027
Study Completion
Last participant's last visit for all outcomes
November 27, 2027
October 9, 2026
October 1, 2026
4 months
October 5, 2026
October 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Adherence to home practice of TM (1 month from baseline)
Adherence to home TM practice will be assessed at 1 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.
1 month
Adherence to home practice of TM (3 months from baseline)
Adherence to home TM practice will be assessed at 3 month post TM instruction, using a self-report form. Adherence to home TM practice will be the number of participants who responded that they did at least one home TM practice session per day on average out of all study participants. The self report survey asks participants over the past week and month how often they have done TM at home with three choices: 1) Twice a day, 2) Once a Day, and 3) Rarely or not at all. "Adherence" to home TM practice will be defined as at least one home TM practice session per day on average on this survey.
3 month
Percentage of participants who attend 6 of the 8 training sessions over the course of the 3-month study
Attendance at TM training sessions (feasibility) will be quantified as a binary outcome (either yes or no) based on whether at least 80% of the participants attend 6 of the 8 training sessions over the course of the 3 month study.
3 months
Change in Level of Anxiety from Baseline to 1 month
Anxiety symptoms will be evaluated between baseline and 1 month with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire. The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.
baseline, 1 month
Change in Level of Anxiety from Baseline to 3 months
Anxiety symptoms will be evaluated between baseline and 3 months with the Generalized Anxiety Disorder-7 (GAD-7) which is a brief 7-item anxiety questionnaire . The survey has 7 question prompts evaluating anxiety symptoms over the past 2 weeks and ranges from the lowest score of 0 to highest total score of 21. The highest score indicates severe anxiety while the lowest score indicates minimal anxiety.
baseline, 3 months
Change in Depression Score from Baseline to 1 Month
The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 1 month.
baseline, 1 month
Change in Depression Score from Baseline to 3 Months
The depression score will be measured by the NIH Promis Emotional Distress-Depression Short Form 6a. The survey has 6 questions prompts evaluating depression levels over the past week. The survey ranges from a lowest score of 0 indicating minimal to no depression and a highest score of 30 indicating severe depression. These surveys will evaluate change in depression from baseline to 3 months.
Baseline, 3 months
Change in Burnout Score from Baseline to 1 Month
Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently: * Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion * Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism * Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and more accomplishment.
baseline, 1 month
Change in Burnout Score from Baseline to 3 Months
Changes in feelings of burnout will be measured by the Maslach Burnout Inventory for Medical Personnel and will be assessed between baseline and 1 month. This survey has 22 question prompts related to how the employee feels from work related stress over the course of year. Respondents rate items on a frequency scale from 0 (Never) to 6 (Every day). The scores for the following three categories are added up independently: * Emotional Exhaustion (EE): 9 items summed to a range of 0 to 54. Higher scores mean greater emotional depletion while lower score indicate less emotional exhaustion * Depersonalization / Cynicism (DP): 5 items summed to a range of 0 to 30. Higher scores mean greater detachment and cynicism while lower scores indicate less detachment or cynicism * Personal Accomplishment (PA): 8 items summed to a range of 0 to 48. Lower scores indicate reduced professional efficacy and a higher risk of burnout while higher scores indicate less burnout risk and greater accomplishment
Baseline, 3 months
Change in Sleep Disturbance from Baseline to 1 Month
Change in sleep disturbance between 1 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.
baseline, 1 month
Change in Sleep Disturbance from Baseline to 3 Month
Change in sleep disturbance between 3 month and baseline will be evaluated with the Insomnia Severity Index which has 7 question prompts. The survey ranges from a low score of 0 indicating no sleep disturbance to a maximum score of 28 indicating severe clinical insomnia.
Baseline, 3 Months
Secondary Outcomes (4)
Change Mental Well-Being from Baseline to 1 month
baseline, 1 month
Change in Mental Well Being from Baseline to 3 Months
baseline, 3 month
Change in Resilience Score from Baseline to 1 Month
baseline, 1 month
Change in Resilience Score from Baseline to 3 Months
Baseline, 3 Months
Study Arms (1)
Transcendental Meditation
EXPERIMENTALParticipants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes
Interventions
Participants will undergo a TM training program of nine sessions and practice the TM technique twice daily for approximately 20 minutes.The TM training program will include a total of 9 sessions conducted by experienced certified TM instructors: an introductory session (Session 0, described above), core instruction consisting of 4 sessions taught on 4 consecutive days (Sessions 1-4, 60-75 minutes each), followed by 4 follow-up sessions offered at intervals over the following 3 months (Sessions 5-8, 45 minutes each). All 9 sessions will be completed within 3.5 months from the time of the first session.
Eligibility Criteria
You may qualify if:
- Be 18 years of age or older
- Be a full-time employee at Weill Cornell Medicine or NewYork-Presbyterian Hospital.
- Agree to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
- Agree to complete a battery of self-report baseline and post-test surveys online (1-month and 3-months post baseline).
- If being treated with psychoactive medications, have maintained a stable regimen for at least two months prior to enrollment.
- Can commit to remaining in the New York area for 3 ½ consecutive months (with the exception of brief trips, e.g., weekend trips) for the duration of the study period (baseline measures through 3-month post-testing).
You may not qualify if:
- Are younger than 18 years of age.
- Are already instructed in the Transcendental Meditation technique.
- Are not a full-time employee at Weill Cornell Medical College or NewYork-Presbyterian Hospital.
- Are unwilling to complete the entire TM training program of eight sessions and practice the TM technique twice daily for approximately 20 minutes.
- Are unwilling to complete a battery of self-report surveys online at baseline, at one month, and at three months post-baseline.
- Have an unstable regimen of psychoactive medications in the past two months or psychiatric hospitalization in the last six months, per self-report.
- Are unable to commit to remaining in the New York area for 3 ½ consecutive months (with the exception of brief trips, e.g., weekend trips) for the duration of the study period (baseline measures through 3-month post-testing).
- This study will not include Adults unable to consent, Individuals who are not yet adults (infants, children, teenagers), and prisoners. The study may include pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medicine, Starr Facility
New York, New York, 10065, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Osborne, MD, PhD
Weill Cornell Medicine Department of Nuclear Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2026
First Posted
October 9, 2026
Study Start (Estimated)
November 15, 2026
Primary Completion (Estimated)
March 15, 2027
Study Completion (Estimated)
November 27, 2027
Last Updated
October 9, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share